Levothyroxine sodium and Asthenopia - a phase IV clinical study of FDA data

Summary:

Asthenopia is reported as a side effect among people who take Levothyroxine sodium (levothyroxine sodium), especially for people who are female, 60+ old, also take Oxervate, and have Neurotrophic keratopathy.

The phase IV clinical study analyzes which people have Asthenopia when taking Levothyroxine sodium. It is created by eHealthMe based on reports of 122,907 people who have side effects when taking Levothyroxine sodium from the FDA, and is updated regularly.

What is Levothyroxine sodium?

Levothyroxine sodium has active ingredients of levothyroxine sodium. It is often used in hypothyroidism. eHealthMe is studying from 129,812 Levothyroxine sodium users. Check the latest studies of Levothyroxine sodium.

What is Asthenopia?

Asthenopia (eyestrain-tiredness of the eyes caused by prolonged close work by a person with an uncorrected vision problem) is found to be associated with 467 drugs and 627 conditions by eHealthMe. Check the latest studies of Asthenopia.

On Jul, 14, 2026

122,907 people reported to have side effects when taking Levothyroxine sodium.
Among them, 28 people (0.02%) have Asthenopia.

Could Levothyroxine sodium cause Asthenopia?

Among these 28 people:

What is the gender of people who have Asthenopia when taking Levothyroxine sodium? *

female: 96.3 %
male: 3.7 %

What is the age of people who have Asthenopia when taking Levothyroxine sodium? *

What are other drugs people take besides Levothyroxine sodium? *

Oxervate: 7 people, 25.00%
Vitamin B12: 5 people, 17.86%
Prednisone: 4 people, 14.29%
Vitamins: 4 people, 14.29%
Restasis: 4 people, 14.29%
Ginkgo: 3 people, 10.71%
Fml Forte: 3 people, 10.71%
Dicyclomine Hydrochloride: 3 people, 10.71%
Estratab: 3 people, 10.71%
Premarin: 3 people, 10.71%

What are other side effects people have besides Asthenopia? *

Fatigue (feeling of tiredness): 11 people, 39.29%
Eye Pain: 7 people, 25.00%
Headache (pain in head): 6 people, 21.43%
Vision Blurred: 4 people, 14.29%
Transient Ischaemic Attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow)): 4 people, 14.29%
Abdominal Pain Upper: 4 people, 14.29%
Depression: 4 people, 14.29%
Eye Irritation: 4 people, 14.29%
Dyspnea (difficult or laboured breathing): 4 people, 14.29%
Ocular Hyperaemia (an abnormally large amount of blood in eye): 4 people, 14.29%

What are the existing conditions these people have? *

Neurotrophic Keratopathy (decreased corneal sensitivity and poor corneal healing): 7 people, 25.00%
High Blood Pressure: 4 people, 14.29%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 10.71%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 3 people, 10.71%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 3 people, 10.71%
Bipolar Disorder (mood disorder): 2 people, 7.14%
Chronic Thyroiditis (long lasting inflammation of thyroid gland): 2 people, 7.14%
Depression: 2 people, 7.14%
Insomnia (sleeplessness): 2 people, 7.14%
Joint Pain: 1 person, 3.57%

* Approximation only. Some reports may have incomplete information.

Do you take Levothyroxine sodium and have Asthenopia?

- Check whether Asthenopia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Levothyroxine sodium:

Levothyroxine sodium (129,812 reports)

Asthenopia treatments and more:

Asthenopia (5,947 reports)

Browse all side effects of Levothyroxine sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Asthenopia:

Asthenopia (467 drugs)

Browse all the conditions that are associated with Asthenopia:

Asthenopia (627 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on levothyroxine sodium (the active ingredients of Levothyroxine sodium) and Levothyroxine sodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.